Exagen Shares Are Trading Higher After the Company Reported Better Than Expected Q4 FY2023 Earnings and Issued FY2024 Guidance
Exagen公布的第四季度的 FY2023 收益好于预期并发布了 FY2024 指引后,该公司股价走高
Exagen Shares Are Trading Higher After the Company Reported Better Than Expected Q4 FY2023 Earnings and Issued FY2024 Guidance
Exagen公布的第四季度的 FY2023 收益好于预期并发布了 FY2024 指引后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧